The Dollar was the catalyst all along.

...

This week we're looking at the stock from the Metal sector.

We retired our "Five Bull Market Barometers" in 2020 to make room for a new weekly post that's focused on the three most important charts for the week ahead.

This is...

The largest insider buy on today's list is a Form 4 filing by RA Capital Management.

The hedge fund reported a purchase of roughly $25 million in Fulcrum Therapeutics Inc $FULC, increasing its ownership stake to 23.8%.

From the Desk of Kimmy Sokoloff

$MSFT reported last night, and, at first, it rallied above $250. And then management had their conference call.

We'll see how it acts, if dip-buyers show up or it just heads...

Vega risk is real.

— Sean McLaughlin, NLD 📈 (@chicagosean) January 24, 2023

I tweeted that earlier today as I was feeling my...

From the Desk of Kimmy Sokoloff

There was a major glitch at the New York Stock Exchange today, and it really did a number on the opening of the market.

...

From the Desk of Steve Strazza @Sstrazza

Last week we held our January Monthly Conference Call, which Premium Members can access and rewatch...

From the desk of Willie Delwiche.

Incoming economic data has been weaker than...

From the desk of Steve Strazza @Sstrazza

Our Top 10 Charts Report was just published.

In this weekly note, we highlight 10 of the most important charts or themes we’re currently seeing in asset classes around the world.

From the Desk of Louis Sykes @haumicharts

I have to get this off my chest.

Wherever I look on Twitter, people are complaining about this rally.

They say it's manipulated.

They say it's all a conspiracy driven by...

With stocks off to a very strong start to the year, we're certainly setting ourselves up for a positive January.

There is still about a week left, but the S&P500 is...

The largest insider buy on today's list is a Form 4 filing by EcoR1 Capital LLC, which reported a purchase of roughly $2.9 million in Zymeworks Inc $ZYME.

EcoR1 Capital also filed a Form 13G, disclosing a stake of 7.80% in the cancer biotech...

From the Desk of Kimmy Sokoloff

The futures are indicating lower this morning. A healthy digesting is warranted.

I'd like to see 396, roughly, held over the next few days on $SPY.

If we push past 402...

From the desk of Steve Strazza @Sstrazza

Check out this week's Momentum Report, our weekly summation of all the major indexes at a Macro, International, Sector, and Industry Group level.

By analyzing the short-term...